QUANTGENE-LOGO-STACKED-SMALL.png
 

INDUSTRY - HEALTH

Unlocking Precision Medicine

STRATEGY  | WEB | BRAND DEVELOPMENT   

Quantgene has developed the world’s first single-molecule, cell-free DNA (cfDNA) sequencing platform to investigate the mutational landscape of your blood with unprecedented accuracy. It can provide deep information about a broad range of clinical conditions, including cancer, at earlier stages than conventional methods. Our proprietary technology is leading the way into the future of medicine: a world in which key diseases are detected and effectively treated well before they become life-threatening.

Qgene-web.jpg

SEARCHING FOR THE SIGNAL

Quantgene's cell-free DNA platform allows clinical researchers to detect and profile key diseases with single-molecule precision.

EMERGENCE

We worked with the Quantgene team to bring the concept to life through digital and print materials, press releases, and online. The new brand has helped launch Quantgene nationally.

IMPACT

Emergence is working with Quantgene to launch the research platform for clinical oncologists and other physicians over the coming year.